Crestor 10mg(Rosuvastatin 10mg), Glucodown OR SR 750mg(Metformin SR 750mg)
Phase 1Completed 0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Pharmacokinetics and Drug Interaction of Crestor and Glucodown SR
Conditions
Pharmacokinetics and Drug Interaction of Crestor and Glucodown SR
Trial Timeline
Dec 1, 2011 → May 1, 2012
NCT ID
NCT01526317About Crestor 10mg(Rosuvastatin 10mg), Glucodown OR SR 750mg(Metformin SR 750mg)
Crestor 10mg(Rosuvastatin 10mg), Glucodown OR SR 750mg(Metformin SR 750mg) is a phase 1 stage product being developed by Yuhan for Pharmacokinetics and Drug Interaction of Crestor and Glucodown SR. The current trial status is completed. This product is registered under clinical trial identifier NCT01526317. Target conditions include Pharmacokinetics and Drug Interaction of Crestor and Glucodown SR.
What happened to similar drugs?
5 of 5 similar drugs in Pharmacokinetics and Drug Interaction of Crestor and Glucodown SR were approved
Approved (5) Terminated (0) Active (0)
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01526317 | Phase 1 | Completed |
Competing Products
20 competing products in Pharmacokinetics and Drug Interaction of Crestor and Glucodown SR